Exploring better strategies for EGFR antibodies in colon cancer

Lancet Oncol. 2014 May;15(6):549-50. doi: 10.1016/S1470-2045(14)70137-8. Epub 2014 Apr 3.

Author

Andrés Cervantes¹

Affiliation

¹ INCLIVA Biomedical Research Institute, University of Valencia, Hospital Clínico de Valencia, Av Blasco Ibáñez, 17, 46010 Valencia, Spain. Electronic address: andres.cervantes@uv.es.

PMID: 24703530
DOI: 10.1016/S1470-2045(14)70137-8

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Cetuximab
Colorectal Neoplasms / drug therapy*
Female
Humans
Male

Substances

Antibodies, Monoclonal, Humanized
Cetuximab